Stay updated on Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Recruitment status shows enrollment is closed, and new sections like How to Read a Study Record, Common Questions, How to Join a Study, and related topics have been added to guide users through the study information.
    Difference
    0.5%
    Check dated 2026-06-14T03:10:32.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer now lists Revision: v3.5.5, replacing the previous revision, and several generic links/topics (Lung cancer, related topics, MedlinePlus Genetics) have been removed.
    Difference
    0.2%
    Check dated 2026-06-07T00:20:23.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added related topics and links for Lung cancer and MedlinePlus Genetics to the page's related information section, enhancing navigation to disease context and genetics resources.
    Difference
    0.1%
    Check dated 2026-05-30T20:43:45.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The related topics section loses three items: Lung cancer, related topics:, and MedlinePlus Genetics, narrowing the list of disease tags and external resources associated with the study.
    Difference
    0.1%
    Check dated 2026-05-23T14:14:23.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.3 to v3.5.4, indicating a minor update to the study record. This does not appear to alter the study details themselves.
    Difference
    0.0%
    Check dated 2026-05-16T10:16:09.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page footer revision tag was updated from **v3.5.2** to **v3.5.3**, indicating a site/platform version update rather than a change to the study information.
    Difference
    0.0%
    Check dated 2026-04-24T22:24:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial page.